Chief Medical Officer and President, Clinical Pharmacology Services
Fortrea
Oren Cohen, MD joined Fortrea (previously Covance) in December 2017 to serve as head of Clinical Pharmacology Services and Chief Medical Officer (CMO). Dr. Cohen brings more than 30 years of healthcare, research and clinical development experience to the role, including several senior medical and operational leadership positions at a biotechnology company and another global CRO.
Oren received his MD from Duke University and served his internal medicine internship and residency at The New York Hospital-Cornell Medical Center in New York City. He completed his infectious diseases fellowship at the National Institute of Allergy and Infectious Diseases (NIAID) and stayed on to become an investigator in the Laboratory of Immunoregulation where he conducted basic and translational research on the immunopathogenesis of HIV infection under the supervision of Dr. Anthony Fauci. He served on the national antiretroviral guidelines panel and ultimately served as Assistant Director for Medical Affairs for NIAID.
Oren has published scientific papers in Science, The New England Journal of Medicine, The Lancet, The Journal of Clinical Investigation and Proceedings of the National Academy of Sciences, among others. He is a Fellow of the Infectious Diseases Society of America a member of the Board of Visitors at the Duke University School of Medicine and a Consulting Professor of Medicine at Duke University Medical Center.
Disclosure information not submitted.
Learning Lab brought to you by Fortrea: Managing Complexity in Early Phase Clinical Trials
Thursday, March 28, 2024
3:00 PM – 3:30 PM MDT